Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of glycosides of <i>cistanche deserticola</i> pretreatment on TLR4 expression in liver tissue of hepatic ischemia-reperfusion injury model rats.

Journal of toxicology and environmental health. Part A·2026
Same author

Effects of montelukast a leukotriene inhibitor on gastric cancer MGC803 cells.

Journal of toxicology and environmental health. Part A·2026
Same author

Expression and clinical significance of LTA4H in esophageal squamous cell carcinoma.

Journal of toxicology and environmental health. Part A·2026
Same author

Mechanisms involved in lobetyolin attenuation of cisplatin-induced gastrocnemius muscle atrophy in the mouse.

Journal of toxicology and environmental health. Part A·2026
Same author

Regulatory effects of luteolin on apoptosis and autophagy in lung cancer A549 cells.

Journal of toxicology and environmental health. Part A·2026
Same author

p300/Ahnak1 promotes the depression of I<sub>Ca,L</sub> of atrial myocytes induced by aging.

Biochimica et biophysica acta. Molecular basis of disease·2026

Related Experiment Video

Updated: Feb 11, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.2K

[Research on pharmacometabolomics].

Zhi-Xin Zhang1, Xiao-Yan Gao1

  • 1School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.

Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|April 21, 2018
PubMed
Summary

Pharmacometabolomics uses metabolomics to study drug effects and personalize medicine. This approach analyzes baseline metabotypes and drug responses to predict treatment efficacy and toxicity, paving the way for tailored therapies.

Keywords:
metabolomicsmetabotypepharmacometabolomics

More Related Videos

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
07:56

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses

Published on: June 8, 2022

4.9K
Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation
06:23

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

6.0K

Related Experiment Videos

Last Updated: Feb 11, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.2K
Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
07:56

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses

Published on: June 8, 2022

4.9K
Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation
06:23

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

6.0K

Area of Science:

  • Pharmacometabolomics
  • Life Sciences
  • Individualized Medicine

Background:

  • Pharmacometabolomics is an emerging field utilizing metabolomics to understand drug effects and response variability.
  • It is increasingly applied in individualized medicine research.
  • The core of pharmacometabolomic research involves analyzing baseline metabolic profiles and subsequent drug responses.

Purpose of the Study:

  • To provide an overview of current research applying pharmacometabolomics for predicting individualized drug responses.
  • To summarize key research processes and methodologies within pharmacometabolomics.

Main Methods:

  • Metabolomic analysis of baseline samples.
  • Assessment of drug response phenotypes post-administration.
  • Statistical analysis integrating baseline and response data.

Main Results:

  • Pharmacometabolomic methods integrate individual baseline metabotypes with drug response phenotypes.
  • This integration enables prediction of drug efficacy and toxicity.
  • Provides a foundation for developing personalized medical treatments.

Conclusions:

  • Pharmacometabolomics offers a powerful approach for predicting individualized drug responses.
  • Understanding baseline metabotypes is crucial for tailoring drug therapy.
  • The field supports the advancement of personalized medicine through data-driven insights.